Genuv Inc.

Private

SeoulHealthcare & Life Scienceshttps://genuv.com/

Last Round

Grant

Feb 1, 2024

Total Funding Raised

$24.41M

Company Overview

Genuv Inc. is a biotechnology company that develops treatments for neurodegenerative diseases and immuno-oncology therapeutics using proprietary drug discovery platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

drug discoverybiopharmaceuticalphenotypic screeningantibody discoveryneurodegenerative diseaseimmuno-oncologybiotechCNS drug discoverytransgenic mousemonoclonal antibodyimmunocytokinebiologicssmall moleculedrug licensingpreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genuv Inc. Comps

Public and private peers based on sector, stage, and business model.

Genuv Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genuv Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 1, 2024
Accelerator	Dec 12, 2022
Grant	Dec 10, 2021
Early Funding	Dec 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Sungho Han

Founder and Chief Executive Officer

Founding Team

Genuv Inc. Investors

Notable investors and investment history

Genuv Inc. investors
Investor	Rounds
Kite Entrepreneurship Foundation	Accelerator
Korea Drug Development Fund	Grant
Alzheimer's Drug Discovery Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 23, 2026
Monthly visitors grew 40% MoM.
Dec 1, 2020
Raised $11.4M in early funding.

View all signals

Genuv Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Genuv Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genuv Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range12

Year Founded2016

Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.